<DOC>
	<DOC>NCT00004423</DOC>
	<brief_summary>OBJECTIVES: I. Assess the efficacy and safety of 4-aminosalicylic acid in patients with active Crohn's disease of the small bowel.</brief_summary>
	<brief_title>Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease</brief_title>
	<detailed_description>PROTOCOL OUTLINE: This is a randomized, placebo controlled, multicenter study. Patients are randomized to receive either oral 4-aminosalicylic acid (4-ASA) or placebo twice a day for 12 weeks. After 12 weeks patients who improved with 4-ASA and those who received placebo are given the option of receiving 4-ASA for an additional year. Patients who were randomized to receive 4-ASA and continue treatment after 12 weeks are followed every 3 months for 1 year. Patients who were randomized to receive placebo and begin 4-ASA therapy after 12 weeks are followed monthly for 3 months, then every 3 months for 1 year. Completion date provided represents the completion date of the grant per OOPD records</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Aminosalicylic Acid</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA: Disease Characteristics Active small bowel Crohn's disease established by clinical evaluation and prior radiologic study, endoscopy, surgical findings and/or histopathology Crohn's Disease Activity Index (CDAI) must be between 150 and 450 No ulcerative or infectious colitis or severe perianal disease Prior/Concurrent Therapy Biologic therapy: Not specified Chemotherapy: Stable dose of no greater than 20 mg per day of prednisone allowed Endocrine therapy: No immunosuppressive drugs within the past 3 months No concurrent immunosuppressive drugs Radiotherapy: Not specified Surgery: No impending surgery No prior ileostomy or colostomy Other: No 5aminosalicylates within the past 2 weeks No concurrent 5aminosalicylates No concurrent metronidazol or ciprofloxacin Patient Characteristics Age: 18 to 80 Performance status: Ambulatory Hematopoietic: Not specified Hepatic: No hepatic disease Renal: No renal disease Other: Not pregnant (negative pregnancy test required) Fertile patients must use effective contraception No documented salicylate allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>Crohn's disease</keyword>
	<keyword>gastrointestinal disorders</keyword>
	<keyword>rare disease</keyword>
</DOC>